Cargando…
Discovery of CLEC2B as a diagnostic biomarker and screening of celastrol as a candidate drug for psoriatic arthritis through bioinformatics analysis
BACKGROUND: Psoriatic arthritis (PSA) is a chronic, immune-mediated inflammatory joint disease that is liked to mortality due to cardiovascular disease. Diagnostic markers and effective therapeutic options for PSA remain limited due to the lack of understanding of the pathogenesis. We aimed to ident...
Autores principales: | Niu, Min, Yuan, Jingman, Yan, Meixi, Yang, Ge, Yan, Ziyi, Yang, Xichao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226212/ https://www.ncbi.nlm.nih.gov/pubmed/37246213 http://dx.doi.org/10.1186/s13018-023-03843-0 |
Ejemplares similares
-
An integrative analysis to reveal that CLEC2B and ferroptosis may bridge the gap between psoriatic arthritis and cancer development
por: Li, Xiaobin, et al.
Publicado: (2022) -
Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes
por: Wu, Ming, et al.
Publicado: (2022) -
The genome of Tripterygium wilfordii and characterization of the celastrol biosynthesis pathway
por: Pei, Tianlin, et al.
Publicado: (2021) -
Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol
por: Xiao-pei, Huang, et al.
Publicado: (2018) -
CLEC14A was up-regulated in hepatocellular carcinoma and may function as a potential diagnostic biomarker
por: Yan, Lang, et al.
Publicado: (2022)